STVN Stevanato Group S.p.A.
Stevanato Group S.p.A. (STVN) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.8% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Stevanato Group S.p.A.
Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries.
Sector
Healthcare
Industry
Medical Instruments/Supply